GILEAD SCIENCES, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Gilead Sciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Gilead Sciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1.36B, a 3.2% increase year-over-year.
  • Gilead Sciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$5.13B, a 20.8% increase from 2022.
  • Gilead Sciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$6.47B, a 27.1% increase from 2021.
  • Gilead Sciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$8.88B, a 1253% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.13B +$1.34B +20.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-23
2022 -$6.47B +$2.41B +27.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-23
2021 -$8.88B -$9.65B -1253% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-23
2020 $770M +$8.4B Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 -$7.63B +$4.68B +38% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 -$12.3B -$15.7B -463% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $3.39B +$13.1B Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 -$9.73B -$3.84B -65.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$5.88B -$2.86B -94.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 -$3.03B -$481M -18.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 -$2.54B -$3.11B -552% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-24
2012 $563M -$1.2B -68.1% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
2011 $1.76B +$3.1B Jan 1, 2011 Dec 31, 2011 10-K 2014-02-25
2010 -$1.34B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.